Managing Benign Prostatic Hyperplasia

A new guideline emphasizes an individualized approach tailored to patients' specific symptoms, prostate size, and potential drug side effects.

Sponsoring Organization: American Urological Association (AUA)

Background

The AUA has updated its guideline on management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH). Part 1 addresses medical management, and part 2 covers surgical treatment.

Key Points

Routine initial evaluation should include a relevant history and physical examination, urinalysis, and the International Prostate Symptom Score (IPSS; a 35-point scale). Post-void residual measurements and uroflowmetry are optional at initial assessment.
Initial management should include behavioral and lifestyle modification.
α-blockers are the usual first-line agents; the somewhat differing side-effect profiles of the five available α-blockers can inform patien…

Reviewing Author

Allan S. Brett, MD

Disclosures

Nothing to disclose

Allan S. Brett, MD

Disclosures

Nothing to disclose

Managing Benign Prostatic Hyperplasia

Topics

Background

Key Points

Reviewing Author